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Abstract
Converging lines of evidence point to the involvement of neurons of the centrally projecting Edinger-Westphal nucleus
(EWcp) containing the neuropeptide Urocortin-1 (Ucn1) in excessive ethanol (EtOH) intake and EtOH sensitivity. Here, we
expanded these previous findings by using a continuous-access, two-bottle choice drinking paradigm (3%, 6%, and 10%
EtOH vs. tap water) to compare EtOH intake and EtOH preference in Ucn1 genetic knockout (KO) and wild-type (WT) mice.
Based on previous studies demonstrating that electrolytic lesion of the EWcp attenuated EtOH intake and preference in
high-drinking C57BL/6J mice, we also set out to determine whether EWcp lesion would differentially alter EtOH
consumption in Ucn1 KO and WT mice. Finally, we implemented well-established place conditioning procedures in KO and
WT mice to determine whether Ucn1 and the corticotropin-releasing factor type-2 receptor (CRF-R2) were involved in the
rewarding and aversive effects of EtOH (2 g/kg, i.p.). Results from these studies revealed that (1) genetic deletion of Ucn1
dampened EtOH preference only in mice with an intact EWcp, but not in mice that received lesion of the EWcp, (2) lesion of
the EWcp dampened EtOH intake in Ucn1 KO and WT mice, but dampened EtOH preference only in WT mice expressing
Ucn1, and (3) genetic deletion of Ucn1 or CRF-R2 abolished the conditioned rewarding effects of EtOH, but deletion of Ucn1
had no effect on the conditioned aversive effects of EtOH. The current findings provide strong support for the hypothesis
that EWcp-Ucn1 neurons play an important role in EtOH intake, preference, and reward.
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Introduction
Compulsive use of alcohol (ethanol; EtOH) is thought to arise
from EtOH-induced adaptations within several neural circuits that
together lead to a persistent dysregulation of drug-seeking [1].
Efforts to characterize the maladaptive changes underlying this
phenomenon have identified numerous brain regions and
neurotransmitter systems that work in concert to drive EtOH
reward, excessive EtOH intake, and EtOH withdrawal [2–4].
While earlier studies utilized experimenter-administered EtOH
to map brain areas thought to be important for sensitivity to the
behavioral effects of EtOH, more recent experiments have
improved the face validity of this approach (and narrowed the
list of candidate brain regions) by implementing self-administra-
tion procedures. Specifically, while neural mapping studies showed
that experimenter-administered EtOH induced expression of the
transcription factor c-Fos in several brain areas [5-8], the Edinger-
Westphal nucleus (EW) was the only brain area that, across
multiple strains and species of rodents, also showed elevated c-Fos
expression following oral self-administration of EtOH [9–17].
The EW is a compact region within the ventromedial
periaqueductal gray that extends along the midline between the
caudal division of the ventral tegmental area and the rostral
division of the dorsal raphe nucleus. While this nucleus has been
historically described as a cholinergic population of pregang-
lionic neurons controlling oculomotor functions, more detailed
examinations have revealed that the EW is comprised of two
distinct (yet partially overlapping) nuclei, designated EWpg for the
preganglionic oculomotor neurons, and EWcp for the centrally-
projecting, neuropeptide-containing neurons [18–21]. Following
the initial studies that characterized the unique sensitivity of the
EW to EtOH-drinking, we repeatedly showed that EtOH-induced
expression of c-Fos in the EW was restricted almost completely to
EWcp neurons containing the neuropeptide Urocortin-1 (Ucn1)
[13,22,23].
Ucn1 is a member of the corticotropin-releasing factor (CRF)
family of endogenous ligands (along with CRF, Ucn2, and Ucn3),
and is distinguished from its related peptides by the fact that it
binds to both CRF receptor subtypes (CRF-R1, CRF-R2) with
high affinity [24,25]. Given the prior literature implicating a role
for CRF systems in excessive EtOH intake following dependence
[26] and stress-induced relapse of EtOH-seeking [27], we
hypothesized that EWcp-Ucn1 neurons might also contribute
toward behavioral phenotypes relevant to alcoholism.
This hypothesis was later validated by data from our laboratory
demonstrating that EWcp-Ucn1 protein levels were differentially
expressed between rodent lines that had been selectively-bred for
divergent EtOH phenotypes. In general, these studies indicated
that stronger expression of EWcp-Ucn1 peptide was associated
with a genetic predisposition toward high EtOH intake [14,28,29]
and heightened sensitivity to some (reward, hypothermia, sedation),
but not all (locomotor stimulation) EtOH-related phenotypes
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EWcp in high-drinking C57BL/6J (B6) mice attenuated intake and
preference of EtOH (but not sucrose, quinine, saccharin, or saline)
in a two-bottle choice (2-BC) drinking paradigm [33,34]. Together,
these studies provided converging lines of evidence to support the
claim that EWcp-Ucn1 neurons play an important role in EtOH
sensitivity and EtOH consumption [31].
However, because several other neuropeptide systems co-exist
with Ucn1 in the EWcp [35–39], the possibility remained that
EWcp lesion altered EtOH consumption via a Ucn1-independent
mechanism (i.e., through a different neuropeptide or receptor
expressed in EWcp). Thus, in order to determine whether the
effects of EWcp lesion could be attributed specifically to Ucn1, the
present studies compared the effects of EWcp lesion on 2-BC
intake and preference between mice lacking Ucn1 and their wild-
type littermates. In addition, we set out to test whether genetic
deletion of Ucn1 would decrease EtOH drinking, EtOH-induced
reward, and EtOH-induced aversion in mice containing an intact
EWcp. Finally, we also tested whether genetic deletion of CRF-R2
would alter EtOH-induced reward. The findings presented herein
shed additional light on the contribution of the EWcp to EtOH
intake, and provide further evidence that Ucn1 is an important
neuropeptide for mediating the EWcp’s effects on EtOH
preference and reward.
Materials and Methods
Animals
All protocols were approved by the Oregon Health & Science
University animal care and use committee (protocol A828), and
were performed with strict adherence to the National Institutes of
Health Guidelines for the Care and Use of Laboratory Animals.
We used single gene mutant mice created from embryonic stem
cells that underwent targeted gene inactivation. Ucn1 knockout
(KO) mice generated on a 12961/SvJ x C57BL/6J (B6)
background contained a deletion of exon 2 of the Ucn gene [40],
and CRF-R2 KO mice generated on a 12961/SvJ x B6
background contained a deletion of exons 3–4 of the Crhr2 gene
[41]. Colonies were maintained by backcrossing onto a B6 genetic
background. The Ucn1 KO line was backcrossed onto a B6
background for 10–12 generations, and the CRF-R2 KO line was
backcrossed onto a B6 background for 14 generations. KO and
wild-type (WT) mice used for these studies were littermates,
generated by heterozygous matings. Mice were weaned at 28–32
days of age, isosexually housed, and either underwent surgery at
9–16 weeks of age (EtOH drinking procedures) or underwent
behavioral testing at 8–14 weeks of age (EtOH conditioning
procedures). Importantly, genetic deletion of either Ucn1 or CRF-
R2 does not alter the rate of EtOH elimination [42,43]. All mice
received ad libitum access to food (LabDiet 5001; LabDiet,
Richmond, IN) and water, with the exception of time spent in
the behavioral apparatus (EtOH conditioning experiments only)
and remained on a 12 h light-dark schedule (lights on at 0700 h).
Mice on a B6 genetic background are well-known for their high
levels of EtOH intake and preference, and are the ideal choice for
EtOH drinking studies, particularly 2-BC drinking studies [44].
While mice on a DBA/2J background generally exhibit more
robust levels of EtOH place conditioning than mice on a B6
background [45], we chose to use mice on a B6 genetic
background in order to produce data that would be comparable
to 2-BC drinking experiments, as well as to avoid the time-
consuming and expensive process of backcrossing our KO mice
onto a DBA/2J background.
Surgical Procedures
EWcp lesion surgery was performed similar to previous reports
[33,34] in male Ucn1 KO and WT littermate mice. Immediately
prior to surgery, mice were given a subcutaneous injection of
Rimadyl (Carprofen; 5 mg/kg). Mice were placed under isoflur-
ane anesthesia, secured in a stereotaxic apparatus, and received
either electrolytic lesion of the EWcp or sham surgery. For both
operations, a small hole was drilled through the skull on the
midline (23.4 mm, A/P; a coordinate that lies halfway along the
rostral-caudal axis of the EWcp) and a stainless steel electrode
(SNE-300, Rhodes Medical Instruments, Inc., Woodland Hills,
CA) was guided down into the EWcp nucleus (23.9 mm, D/V).
The electrode was connected to the positive terminal of a lesion-
making device (Model 3500, Ugo Basile, Comerio, Italy). To
ground the animal, the negative terminal was attached to the
mouse’s tail. For sham animals, the electrode remained inactive,
but for lesion animals, the electric current (0.4 mA) was activated
for five seconds.
Following this procedure, the electrode was removed, the skin
was sutured, and animals were single-housed in a cage containing
fresh bedding and food, and a single bottle containing tap water.
Loss of body temperature was avoided by placing the cage on a
heating pad for 30–60 min during the initial recovery period.
Following five-nine days of recovery from surgery, mice were given
access to two 25 mL glass cylinder bottles (both containing tap
water) in order to habituate the animals to drinking from two
bottles in the homecage. Importantly, we have previously shown
that lesions of EWcp do not produce changes in locomotor activity
or the rate of EtOH elimination [33], nor do they produce
changes in anxiety-like behavior [34].
Ethanol Drinking Procedures
Following four days of drinking tap water from two bottles,
individually-housed mice underwent a twelve-day EtOH-drinking
experiment during which they received 24-hour access to two
bottles: one containing tap water, and one containing varying
concentrations of EtOH dissolved in tap water. The experiment
consisted of three phases during which mice had access to either:
3% EtOH and H2O (Days 1–4), 6% EtOH and H2O (Days 5–8),
or 10% EtOH and H2O (Days 9–12). Higher concentrations of
EtOH or other palatable fluids were not tested here because
earlier studies indicated that EWcp lesion did not affect preference
(or avoidance) of several solutions [33,34]. Mice were weighed and
fluid levels from each of the two bottles were recorded on a daily
basis between 1000–1200 h. The locations of the bottles on the
cages (left vs. right) were alternated daily to avoid the potential
confound of an inherent side preference.
Histology
Immediately following the final day of access to 10% EtOH,
mice were euthanized by CO2 inhalation. Brains were rapidly
dissected, post-fixed overnight in 2% paraformaldehyde in
phosphate-buffered saline (PBS), and cryoprotected in 30%
sucrose in PBS until saturation. Coronal slices of the midbrain,
30 mm thick, were collected using a CM1850 cryostat (Leica
Microsystems) and placed into PBS containing 0.3% NaN3 for
storage. Six to eight sections spanning the rostral-caudal extent of
the EWcp were selected from each animal and underwent Thionin
staining. Sections were mounted on clear glass slides, coverslipped,
and viewed with the 56objective on a Leica DM4000 microscope
for examination of the location of the lesion (and verification of the
absence of damage in sham mice). Images were acquired with the
MicroPublisher 3.3 RTV in conjunction with Q-Capture (Q-
Imaging, Surrey, BC, Canada). Animals containing lesions that
EWcp-Ucn1 in Ethanol Preference
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included in the ‘‘Lesion’’ group, and all sham animals were
included in the ‘‘Sham’’ group for statistical analysis of drinking
data. An experimenter blinded to the behavioral data was
responsible for excluding mice based on incorrect placement of
the lesion.
Statistical Analysis – Ethanol Drinking
Based on the appropriate concentration, EtOH consumption in
mL was converted to grams and divided by the animal’s body
weight to give daily intake scores expressed in grams per kilogram
(g/kg). Daily EtOH preference was calculated by dividing EtOH
consumption in mL by the total fluid consumption in mL (EtOH
consumption + H2O consumption). Total fluid consumption
scores were divided by the animal’s body weight to give values
expressed in mL/kg. Data points across each of the four days of
drinking at the 3%, 6%, and 10% concentrations of EtOH were
averaged within each animal to produce a single value for EtOH
intake (g/kg), EtOH preference, and total fluid consumption (mL/
kg) at each of the three phases of the experiment.
Each dependent variable was analyzed by a 26263 repeated
measures ANOVA design with genotype (KO, WT) and surgery
(Sham, Lesion) as the between-subjects factors, and EtOH
concentration (3%, 6%, 10%) as the repeated measure. Significant
interactions with EtOH concentration were followed by simple
main effect analyses evaluating the impact of surgery and genotype
among the three EtOH concentrations. Significant interactions
between surgery and genotype were followed by simple main effect
analyses evaluating the impact of EtOH concentration and surgery
among the two genotypes. Post-hoc comparisons between the four
individual groups at each of the three phases of the experiment
were made using Bonferroni contrasts corrected for multiple
comparisons (significance threshold at p,.0083). For all analyses
other than post-hoc comparisons, significance threshold was set at
p,.05. Data are expressed as mean + standard error of the mean
(SEM).
Conditioning Apparatus
The apparatus for EtOH conditioning consisted of four
identical boxes measuring 30615615 cm that contained six
detectors placed 2.2 cm above the floor for acquisition of spatial
location and locomotor activity data. The conditioned stimuli
consisted of two unbiased tactile cues: ‘‘grid’’ and ‘‘hole’’ floors,
which were interchangeable within the apparatus. This allowed
the experimenter to arrange the cues in either a ‘‘split’’
configuration (for Pre-Test and Test), or a ‘‘matching’’ configu-
ration (for Conditioning). The apparatus and conditioned stimuli
have been described in detail elsewhere [46].
Ethanol Conditioning Procedures
In the first set of conditioning experiments (EtOH-CPP), male
and female Ucn1 and CRF-R2 KO and WT littermate mice
(n=7–15 per line, per sex, per genotype) were tested for the
conditioned rewarding effects of EtOH using a slight variant of a
well-established, unbiased place conditioning protocol in which
pre-session exposure to EtOH results in a significant preference for
the EtOH-paired environment [46].
On Day 1 (Pre-Test), mice were weighed and given a saline
injection (12.5 mL/kg, i.p.) before being placed into the apparatus
containing the two different tactile floor cues (‘‘split’’ configura-
tion; one floor on each side of the chamber) for 30 min. On Days
2–9, mice underwent daily 5-min conditioning trials. Mice in the
‘‘Grid+’’ subgroup were weighed and injected with EtOH (2 g/kg,
20% v/v, i.p.) immediately before being placed into the apparatus
containing the grid floor cue (‘‘matching’’ configuration; same floor
on both sides of the chamber). On alternating days, mice were
weighed and injected with saline before being placed into the
apparatus containing the hole floor cue on both sides of the
chamber. Mice in the ‘‘Grid-‘‘ (or ‘‘Hole+’’) subgroup were treated
in a manner opposite from that of Grid+ mice, such that they were
weighed and injected with EtOH prior to being placed into the
apparatus containing the hole floor cues on both sides, while on
alternating days, they were weighed and injected with saline prior
to being placed into the apparatus containing the grid floor on both
sides. On Day 10, all mice were weighed and received a saline
injection before being placed into the apparatus containing both
floor cues (one on each side) for 30 min.
In the second set of conditioning experiments (EtOH-CPA),
male and female Ucn1 KO and WT littermate mice (n=14–23
per sex, per genotype) were tested for the conditioned aversive
effects of EtOH using a slight variant of a well-established protocol
in which post-session exposure to EtOH results in a significant
aversion of the EtOH-paired environment [46,47]. The protocol
used for EtOH-CPA was identical to that described for EtOH-
CPP, except that mice were weighed and injected with either
EtOH or saline immediately after being removed from the
apparatus on Days 1–9. A post-session injection on Day 10 was
unnecessary, because the experiment was complete by the end of
the behavioral Test session. Importantly, the dose and preparation
of EtOH were identical for CPP and CPA experiments.
In order to minimize variation in the conditioning response that
could occur based on conditioning subgroup (Grid+ vs. Grid-),
conditioning order (EtOH/saline vs. saline/EtOH), and side of the
EtOH-paired floor during Pre-Test and Test (left vs. right), all of
these variables were fully counterbalanced among all groups in all
conditioning experiments.
Statistical Analysis – Ethanol Conditioning
The percent time spent on the grid floor on Day 10 (Test)
relative to Day 1 (Pre-Test) was used as the dependent variable (D
%Time on Grid Floor). Because three-way ANOVAs of all
conditioning experiments yielded no significant main or interact-
ing effects of sex, analyses were collapsed across males and females,
and data were analyzed by two-way ANOVA with between-
subjects factors of genotype (KO, WT) and subgroup (Grid+,
Grid-). Significant interactions between genotype and subgroup
were followed by simple main effect analyses evaluating the impact
of subgroup separately across the two genotypes. For all
conditioning analyses, significance threshold was set at p,.05.
Data are expressed as mean 6 SEM.
Results
Histology
Of the 51 mice that received lesion surgery, Thionin-stained
tissue revealed successful targeting and ablation of the EWcp in 29
cases. Importantly, the percentage of successful surgeries was not
significantly different between Ucn1 KO and WT mice (16/27 vs.
13/24). Successful lesions were targeted primarily to the anterior
and medial EWcp (23.4 mm from bregma), and caused
destruction of this region with minimal damage to surrounding
areas (Figure 1A). Animals that received sham surgery showed no
evidence of damage to the EWcp or surrounding tissue (Figure 1B).
EWcp lesion decreases EtOH intake
The initial analysis of EtOH intake indicated differential effects
of surgery across the three concentrations (surgery x concentration
interaction; F2,120=7.14, p,.005; Figure 2A). Follow-up analyses
EWcp-Ucn1 in Ethanol Preference
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and 10% concentrations of EtOH (simple main effects of surgery;
both F1,60.7.2, both p,.01), but not the 3% concentration of
EtOH (p=.65).
Although EWcp lesion appeared to differentially affect Ucn1
KO and WT mice at the 6% concentration of EtOH, this
interaction did not reach significance (p=.103). Nevertheless, post-
hoc comparisons at the 6% concentration revealed greater intakes
in the WT-Sham group relative to both the WT-Lesion group
(p=.002) and the KO-Sham group (p=.005). No other between-
group comparisons were significant, indicating that EWcp lesion
dampened 6% EtOH intake only in mice expressing Ucn1, and
that deletion of Ucn1 dampened 6% EtOH intake only in mice
with an intact EWcp.
However, at the 10% concentration of EtOH, the simple main
effect of surgery was far from interacting significantly with
genotype (p=.85), indicating that EWcp lesion was equally
effective at reducing intake of 10% EtOH in both Ucn1 KO
and WT mice.
Deletion of Ucn1 decreases EtOH preference only in mice
with an intact EWcp, and EWcp lesion decreases EtOH
preference only in mice expressing Ucn1
Analysis of EtOH preference indicated that there were
differential effects of surgery across the two genotypes (surgery
x genotype interaction; F1,60=5.55, p,.05). Follow-up analysis
revealed that while EtOH preference was significantly dampened
by destruction of the EWcp in Ucn1 WT mice (simple main effect
of surgery; F1,28=22.28, p=.0001), EWcp lesion had no effect on
preference in Ucn1 KO mice (p=.84). Furthermore, while
preference increased in parallel with greater concentrations of
EtOH among Ucn1 WT mice (simple main effect of concentra-
tion; F2,56=3.24, p,.05), Ucn1 KO mice were strikingly resistant
to effects of EtOH concentration on preference (p=.36).
The conclusion that deletion of Ucn1 dampened EtOH
preference only in Sham mice but not Lesion mice, and that
EWcp lesion dampened EtOH preference only in Ucn1 WT mice
but not Ucn1 KO mice, was supported by post-hoc comparisons at
the 6% and 10% concentrations of EtOH, in which the WT-Sham
group displayed significantly greater preference than each of the
other three groups (all p#.005). No other group comparisons
reached significance (all p..25).
Deletion of Ucn1 and/or lesion of EWcp do not alter total
fluid consumption
Total fluid consumption varied significantly across the different
concentrations of EtOH (main effect of concentration;
F2,120=4.50, p,.05; Figure 2C). However, no main or interacting
effects with surgery or genotype were found, and no significant
post-hoc comparisons were identified between any of the four
groups at any of the three EtOH concentrations.
Deletion of Ucn1 abolishes EtOH-induced CPP
Consistent with previous studies demonstrating the unbiased
nature of the tactile floor cues used in our EtOH conditioning
studies [48], Ucn1 KO and WT mice spent approximately 50% of
their time on the grid floor during the Pre-Test, and this did not
differ by genotype or subgroup (data not shown). Following
conditioning, preference for the EtOH-paired floor was apparent
in Ucn1 WT mice, but not Ucn1 KO mice (genotype x subgroup
interaction; F1,45=4.96, p,.05; Figure 3A). The conclusion that
deletion of Ucn1 abolished EtOH-induced CPP was supported by
simple main effect analyses evaluating the impact of subgroup
separately across the two genotypes. While strong conditioning
was apparent in Ucn1 WT mice (simple main effect of subgroup;
F1,26=14.45, p,.001), this effect was not apparent in Ucn1 KO
mice (p=.99).
Deletion of CRF-R2 abolishes EtOH-induced CPP
Similar to Ucn1 KO and WT mice, CRF-R2 KO and WT mice
spent approximately half of their time on the grid floor during the
Pre-Test, and this did not differ across genotypes or subgroups
(data not shown). Following conditioning, preference for the
EtOH-paired floor was apparent in CRF-R2 WT mice, but not
CRF-R2 KO mice (genotype x subgroup interaction; F1,31=6.22,
p,.05; Figure 3B). The conclusion that deletion of CRF-R2
abolished EtOH-induced CPP was supported by simple main
effect analyses, in which strong conditioning was apparent in
Figure 1. EWcp lesion histology. Representative photomicrographs of Thionin-stained sections from anterior, medial, and posterior EWcp
(numbers indicate distance from bregma) taken from mice that underwent (A) successful EWcp lesion surgery or (B) sham surgery. Lesions generally
ablated large portions of the anterior and medial EWcp, leaving minimal damage to surrounding tissue. Sham animals displayed no evidence of
damage to the EWcp, despite occasional visibility of the electrode tract (posterior panel). White arrows point toward intact EWcp observed in sham
animals.
doi:10.1371/journal.pone.0026997.g001
EWcp-Ucn1 in Ethanol Preference
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26997CRF-R2 WT mice (simple main effect of subgroup; F1,15=25.24,
p,.0005), but not CRF-R2 KO mice (p=.56).
Deletion of Ucn1 does not alter EtOH-induced CPA
In a separate experiment using an EtOH conditioning protocol
that produces CPA rather than CPP, Ucn1 KO and WT mice
again spent approximately 50% of their time on the grid floor
during the Pre-Test, and this did not differ by genotype or
subgroup (data not shown). While EtOH conditioning resulted in a
significant CPA (main effect of subgroup; F1,68=5.25, p,.05;
Figure 3C), this effect did not interact significantly with genotype
(p=.40), indicating that Ucn1 KO and WT mice were equally
sensitive to the conditioned aversive effects of EtOH.
Discussion
The principal findings of the current study were that EtOH
intake and preference depended on an interaction between
whether or not mice expressed Ucn1, and whether or not mice
Figure 2. Effects of EWcp lesion on 2-BC EtOH drinking in Ucn1
KO and WT mice. (A) EtOH Intake (g/kg), (B) EtOH Preference, and (C)
Total Fluid Consumption (mL/kg) of male Ucn1 KO and WT mice
following either sham surgery or EWcp lesion. Asterisks indicate
significant difference from the respective WT-Sham group (*p#.005,
**p#.001, ***p,.0001). Numbers in parentheses indicate group sizes.
The same animals contributed to panels A, B, and C.
doi:10.1371/journal.pone.0026997.g002
Figure 3. Involvement of Ucn1 and CRF-R2 in EtOH-induced
reward and aversion. Graphs show percent change in time spent on
Grid Floor between the Pre-Test and the Test following (A) EtOH-CPP in
Ucn1 KO and WT mice, (B) EtOH-CPP in CRF-R2 KO and WT mice, and (C)
EtOH-CPA in Ucn1 KO and WT mice. Multiple asterisks indicate
significant difference between WT subgroups (**p,.001, ***p,.0005).
Single asterisk indicates significant main effect of subgroup (*p,.05).
Numbers in bars indicate group sizes.
doi:10.1371/journal.pone.0026997.g003
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demonstrated that Ucn1 signaling (most likely via CRF-R2) is
necessary for the conditioned rewarding effects of EtOH, and that
this cannot be attributable to a generalized learning deficit in
Ucn1 KO mice. Together, these results indicate that EWcp-Ucn1
neurons influence the magnitude of EtOH intake and preference
for EtOH-containing fluids, and that this involvement is likely
related to Ucn1’s role in mediating sensitivity to the rewarding, but
not aversive, effects of EtOH.
Although EWcp lesion and/or deletion of Ucn1 were both
capable of attenuating measures of EtOH consumption, it is
important to note that these manipulations differentially affected
the outcomes of EtOH intake vs. EtOH preference. When
examining EtOH intake, our analyses revealed that EWcp lesion
reduced drinking in both Ucn1 KO and WT mice. Although
examination of the 6% concentration suggested a potential
interaction between genotype and surgery, examination of the
10% concentration indicated that EWcp lesion was equally
effective at reducing EtOH-drinking in both Ucn1 KO and WT
mice. The fact that EWcp lesion decreased 10% intake in mice
lacking Ucn1 suggests that other neural systems in the EWcp
besides Ucn1 may also contribute to intake of 10% EtOH.
Indeed, the receptor for the orexigenic peptide, ghrelin (growth
hormone secretagogue receptor; Ghsr) is densely expressed in the
mouse EWcp [36], and our laboratory reported that systemic
administration of a Ghsr antagonist not only prevented EtOH-
induced neural activity within the EWcp, but also reduced intake
of 20% EtOH in a model of binge-like drinking [16].
Furthermore, the receptor for the anorexigenic peptide, leptin
(Lepr) is also expressed in the mouse EWcp, and Lepr signaling
increases the expression of Ucn1 peptide by directly activating
EWcp neurons [39]. In addition, mutant mice that are either
leptin-deficient (ob/ob) or leptin-resistant (db/db) showed de-
creased EtOH preference relative to their wild-type littermates in a
2-BC procedure [49]. These studies suggest that signaling via EW-
Ghsr and/or EW-Lepr may be important for EWcp-Ucn1’s effects
on EtOH preference and reward. Finally, Ucn1 is also highly co-
localized in the EWcp with the anorexigenic neuropeptide
cocaine- and amphetamine-regulated transcript (CART) [35,50],
and although a role for CART in EtOH-related behaviors
has been supported by several studies [51–53], the contribution
of EWcp-CART neurons to these phenotypes has not yet been
thoroughly examined.
The EWcp also expresses high levels of the peptides cho-
lecystokinin, nesfatin-1, and neuropeptide B [54–57]. Since these
peptides have anorexic properties, it is logical to assume that they
could also contribute to EWcp’s involvement in consummatory
behaviors. This would be in agreement with our observations that
EWcp lesions can alter fluid consumption [33,34]. However, the
reductions in EtOH intake observed here were not simply due to a
non-specific decrease in consumption, because the total volume of
fluid consumption was not affected (Fig. 2C), and the effect on
EtOH preference was dependent on both Ucn1 genotype and the
type of surgery, as discussed below.
In contrast to effects on EtOH intake, analysis of EtOH pre-
ference revealed a significant interaction between surgery and
genotype. Post-hoc comparisons at concentrations of both 6% and
10% confirmed that deletion of Ucn1 reduced preference only in
mice with an intact EWcp, and that lesion of EWcp reduced
preference only in mice expressing Ucn1. These findings provide
strong evidence that EWcp-Ucn1 neurons are necessary for driving
high EtOH preference, and suggest that our previous report of
dampened EtOH preference in EWcp-lesioned B6 mice can be
attributed primarily to the reduction of Ucn1-positive terminals
within EWcp target regions [33]. The potential dissociation
between Ucn1’s involvement in regulation of EtOH preference and
the contribution of other EWcp peptide systems to regulation of
EtOH intake is intriguing, and requires further investigation.
One potential caveat of examining genetically-engineered KO
mice is that observed effects can sometimes be better attributed to
developmental compensations within systems related to the deleted
gene, rather than to the absence of the gene itself. In fact, one
possible explanation for why we uncovered a role for Ucn1 in
EtOH preference, but not EtOH intake is that this effect was masked
by developmental compensations in Ucn1 KO mice. However,
because Ucn1 is the only component of the CRF system that is
expressed in the EWcp, and because the EWcp is the primary site
of Ucn1 expression in the mammalian brain [58-60], our
observation that EWcp lesion differentially affected EtOH
preference in Ucn1 KO and WT mice suggests that the effects
of Ucn1 deletion on EtOH-related behaviors can be primarily
ascribed to the actions of EWcp-Ucn1 neurons. Furthermore, we
have previously shown that Ucn1 is only expressed postnatally in
the EWcp [61], limiting the potential impact of compensations on
development. Indeed, converging lines of evidence provide
additional support for the involvement of EWcp-Ucn1 neurons
in EtOH sensitivity [14,31].
The current data complement a wealth of existing literature on
the contribution of specific components of the CRF system to
EtOH-related behaviors. Importantly, the function of EWcp-Ucn1
neurons appears to differ substantially from the role of CRF-
containing neurons in the central nucleus of the amygdala (CeA).
While we speculate that the involvement of EWcp-Ucn1 neurons
in EtOH preference and reward predominates during the initial
stages of the addiction process, CeA-CRF neurons are thought to
be integral for the transition to EtOH addiction and the negative
reinforcement processes that prevail during dependence and
withdrawal [62,63].
For example, excessive release of CeA-CRF occurs during
EtOH withdrawal [64,65], CeA-CRF mRNA is upregulated
following EtOH dependence [66,67], and CRF’s ability to release
GABA from CeA interneurons is potentiated in EtOH-dependent
rats [67]. Although we have not yet ruled out a potential role for
Ucn1 in EtOH dependence, the current results support a general
framework in which CRF and CRF-related peptides display
unique relationships with distinct aspects of the addiction process.
Indeed, while CRF is required for EtOH-induced psychomotor
sensitization and binge-like EtOH intake, it appears that Ucn1 is
not critical for these behaviors [42,43].
It is important to note that although Ucn1 binds with high
affinity to both CRF receptors [24,25], it remains unclear
specifically which EtOH-related behaviors involve EWcp-Ucn1
actions at CRF-R1 vs. CRF-R2. Numerous reports have demon-
strated that genetic deletion or pharmacological blockade of CRF-
R1 decreases EtOH consumption [42,68–70], and these effects are
generally more pronounced in animals with an extensive history of
EtOH exposure [67,71–77].
In contrast, several studies have concluded that CRF-R2
signaling acts to decrease EtOH consumption [70,78,79]. However,
CRF-R2 regulation of behavior is often reported as bi-directional
[80–82], and one study demonstrated that intra-CeA CRF-R2
activation had opposing effects on EtOH self-administration in
dependent vs. non-dependent rats [83]. Indeed, the observations
that deletion of CRF-R2 blocked EtOH-CPP (Fig. 3B) and
protected against prolonged increases in EtOH preference
following stress [84] indicate that the precise role of CRF-R2
signaling in EtOH-related behavior may rely on a complex
interaction between several experimental variables.
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lesion decreased the number of Ucn1-positive terminals in the
lateral septum and dorsal raphe nucleus [33], and because CRF-
R2 expression is enriched in those areas relative to CRF-R1
[85,86], we have hypothesized that EWcp-Ucn1 mediates its
effects on EtOH-related behaviors primarily via CRF-R2 rather
than CRF-R1. Although this idea is supported by our observation
that Ucn1 KO mice and CRF-R2 KO mice are both resistant to
EtOH-CPP (suggesting that Ucn1 acts via CRF-R2 to mediate the
conditioned rewarding effects of EtOH), this hypothesis awaits
further confirmation. Nevertheless, accumulating evidence sug-
gests that the importance of urocortin peptides and CRF-R2
signaling in mediating emotional states [87,88] and drug-induced
behaviors [89,90] remains underappreciated.
In summary, we utilized two complementary methods (genetic
knockout of Ucn1 and electrolytic lesion of EWcp) in an
examination of 2-BC EtOH consumption, and accompanied
these studies with place conditioning experiments capable of
dissociating sensitivity to the rewarding vs. aversive effects of
EtOH. Taken together, our results implicate the EWcp in EtOH
intake, EWcp-Ucn1 neurons in EtOH preference, and Ucn1/
CRF-R2 in EtOH-induced reward. Future studies examining
different drinking paradigms, different concentrations of EtOH,
potential effects of dependence, and additional EtOH-related
behaviors will assist in delineating the specific components of the
CRF system (and the specific neural substrates) that work in
concert to drive the progression of EtOH addiction.
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